For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
No hero at hand to conquer Babylon before it conquers UK general practice
+Opinion
In print
No hero at hand to conquer Babylon before it conquers UK general practice
Thursday 23 April 2020, 04:07 PM

Virtual health company Babylon has forced the NHS to reallocate millions of pounds to mitigate the disruption it has caused
Ian Powell looks to the UK and finds a virtual health error that lies in wait for some new Kiwi health minister to repeat
The Heather Simpson-led panel that reviewed the health and disability system advocates digital development at every level of the system.
Health is
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.